S6 Saturday Debate 1 Discussion Corrected – Blinatumomab Acute Lymphoblastic Leukemia 1 Min Read9 The discussion revolves around the complexities of Blinatumomab treatment for leukemia, with experts debating the reasons behind the partial clinical…
S7 Debate 2 Discussion- CAR T-cell/Inotuzumab for Relapsed ALL Acute Lymphoblastic Leukemia 1 Min Read25 In a dynamic and insightful debate, leading experts in the field of leukemia treatment delved into the intricacies of optimizing…
S3 Debate 1 Discussion – AML treatment strategies like Masitinib Acute Myelogenous Leukemia 1 Min Read4 The conversation focuses on AML treatments, including arsenic and another frontline approach. Preventing relapses through non-toxic drugs like masitinib is…
